BPC 10mg

BPC-157 (10mg) — Research Overview

BPC-157 (10mg) is a research-grade synthetic pentadecapeptide in a larger volume format for laboratory research protocols requiring higher quantities for multi-condition experimental designs. Originally isolated from a protein found in human gastric juice, BPC-157 has accumulated over 100 preclinical studies since the 1990s across a wide range of tissue model systems.

What the Research Shows

Primary documented mechanisms include VEGFR2 activation and Akt-eNOS signaling (Hsieh et al., Journal of Molecular Medicine, 2017, DOI: 10.1007/s00109-016-1488-y), nitric oxide modulation through endothelial nitric oxide synthase activation (Scientific Reports, 2020, PMC7555539), fibroblast migration enhancement under oxidative stress (Journal of Applied Physiology, DOI: 10.1152/japplphysiol.00945.2010), and growth hormone receptor upregulation in tendon fibroblast models (PMC6271067). A 2025 systematic review in the American Journal of Sports Medicine confirmed preclinical support across connective tissue research models (DOI: 10.1177/15563316251355551).

BPC-157 is classified as a Category 2 bulk drug substance by the FDA. It is not approved for human or veterinary therapeutic use. All musculoskeletal findings come from animal models, primarily rodents.

Quality Documentation

• 99%+ purity — HPLC and Mass Spectrometry verified
• 10mg BPC-157 lyophilized powder
• Batch-specific COA included with every order
• USA tested and fulfilled

Read the full BPC-157 research overview

For laboratory research purposes only. Not for human or veterinary consumption.